📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency. (2024)

First Author: Sheridan M

Attributed to: MOLECULAR CONTROL OF HAEMOGENIC ENDOTHELIUM FATE funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13045-024-01610-0

PubMed Identifier: 39380002

Publication URI: http://europepmc.org/abstract/MED/39380002

Type: Journal Article/Review

Volume: 17

Parent Publication: Journal of hematology & oncology

Issue: 1

ISSN: 1756-8722